Outcomes of Patients with Hematologic Malignancies and COVID-19 Infection: A Report from the ASH Research Collaborative Data Hub

Introduction: The coronavirus disease 2019 (COVID-19) is an illness resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that emerged in late 2019. Many patients with blood cancer have underlying immune dysfunction, and many are treated with chemotherapies and immunotherapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, William A., Neuberg, Donna S., Thompson, John Colton, Tallman, Martin S., Sekeres, Mikkael A., Sehn, Laurie H., Anderson, Kenneth, Goldberg, Aaron D, Pennell, Nathan A, Niemeyer, Charlotte M., Tucker, Emily, Hewitt, Kathleen, Plovnick, Robert M, Hicks, Lisa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
906.Outcomes Research-Malignant Conditions (Myeloid Disease)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330340/
http://dx.doi.org/10.1182/blood-2020-141327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330340/
http://dx.doi.org/10.1182/blood-2020-141327

Ejemplares similares